Melatonin, sleep, and circadian rhythms: Rationale for development of specific melatonin agonists

Sleep Medicine

Volumn 5, Issue 6, 2004, Pages 523-532

  Turek, Fred W ^a   Gillette, Martha U ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Circadian rhythm; Insomnia; Melatonin; Pineal gland; Sleep; Suprachiasmatic nucleus

Indexed keywords

AGOMELATINE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; FURAN DERIVATIVE; HORMONE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; LONG ACTING DRUG; LY 156735; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; MELATONIN RECEPTOR AGONIST; RAMELTEON; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; TEMAZEPAM; UNCLASSIFIED DRUG;

ANXIETY DISORDER; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; HYPNOSIS; HYPOTHALAMUS; INSOMNIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHIFT WORKER; SLEEP PATTERN; SUPRACHIASMATIC NUCLEUS; VISUAL IMPAIRMENT;

ACETAMIDES; ANTIOXIDANTS; HUMANS; HYPOTHALAMUS; INDENES; INDOLES; MELATONIN; RECEPTORS, MELATONIN; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 7044263197     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2004.07.009     Document Type: Review

References (145)

1. A.B. Lerner J.D. Case R.W. Heinzelman Structure of melatonin J Am Chem Soc 81 1959 6084-6085
2. J. Arendt Importance and relevance of melatonin to human biological rhythms J Neuroendocrinol 15 4 2003 427-431
3. L. Tamarkin C.J. Baird O.F. Almeida Melatonin: A co-ordinating signal for mammalian reproduction? Science 227 4688 1985 714-720
4. E. Van Cauter G. Copinschi F.W. Turek Endocrine and other biologic rhythms In: L.J. DeGroot J.L. Jameson (Eds.) Endocrinology 2001 WB Saunders New York 235-256
5. D.J. Dijk C. Cajochen Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG J Biol Rhythms 12 6 1997 627-635
6. K. Krauchi A. Wirz-Justice Circadian clues to sleep onset mechanisms Neuropsychopharmacology 25 5 2001 S92-S96
7. D.C. Klein R.Y. Moore S.M. Reppert Suprachiasmatic nucleus: The mind's clock 1991 Oxford University Press New York
8. R.Y. Moore V.B. Eichler Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat Brain Res 42 1 1972 201-206
9. F.K. Stephan I. Zucker Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions Proc Natl Acad Sci USA 69 6 1972 1583-1586
10. S.M. Reppert M.J. Perlow L.G. et al. Ungerleider Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey J Neurosci 1 12 1981 1414-1425
11. C.A. Fuller R. Lydic F.M. Sulzman et al. Circadian rhythm of body temperature persists after suprachiasmatic lesions in the squirrel monkey Am J Physiol 241 5 1981 R385-R391
12. S.M. Reppert M.J. Perlow H.G. Artman et al. The circadian rhythm of oxytocin in primate cerebrospinal fluid: Effects of destruction of the suprachiasmatic nuclei Brain Res 307 1-2 1984 384-387
13. H.E. Albers R. Lydic P.H. Gander M.C. Moore-Ede Role of the suprachiasmatic nuclei in the circadian timing system of the squirrel monkey. I. The generation of rhythmicity Brain Res 300 2 1984 275-284
14. R.Y. Moore N.J. Lenn A retinohypothalamic projection in the rat J Comp Neurol 146 1 1972 1-14
15. N.H. Zimmerman M. Menaker Neural connections of sparrow pineal: Role in circadian control of activity Science 190 4213 1975 477-479
16. F.W. Turek J.P. McMillan M. Menaker Melatonin: Effects on the circadian locomotor rhythm of sparrows Science 194 4272 1976 1441-1443
17. J. Redman S. Armstrong K.T. Ng Free-running activity rhythms in the rat: entrainment by melatonin Science 219 4588 1983 1089-1091
18. A.J. McArthur M.U. Gillette R.A. Prosser Melatonin directly resets the rat suprachiasmatic circadian clock in vitro Brain Res 565 1 1991 158-161
19. A.J. McArthur A.J. Lewy R.L. Sack Non-24-h sleep-wake syndrome in a sighted man: Circadian rhythm studies and efficacy of melatonin treatment Sleep 19 7 1996 544-553
20. C. Liu D.R. Weaver X. Jin et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock Neuron 19 1 1997 91-102
21. A.J. McArthur A.E. Hunt M.U. Gillette Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: Activation of protein kinase C at dusk and dawn Endocrinology 138 2 1997 627-634
22. B.M. Stone C. Turner S.L. Mills A.N. Nicholson Hypnotic activity of melatonin Sleep 23 5 2000 663-669
23. I.V. Zhdanova R.J. Wurtman H.J. Lynch et al. Sleep-inducing effects of low doses of melatonin ingested in the evening Clin Pharmacol Ther 57 5 1995 552-558
24. P. Lavie Melatonin: Role in gating nocturnal rise in sleep propensity J Biol Rhythms 12 6 1997 657-665
25. D.J. Kennaway H. Wright Melatonin and circadian rhythms Curr Top Med Chem 2 2 2002 199-209
26. T.J. Bartness B.D. Goldman Mammalian pineal melatonin: A clock for all seasons Experientia 45 10 1989 939-945
27. A.J. Lewy S. Ahmed J.M. Jackson R.L. Sack Melatonin shifts human circadian rhythms according to a phase-response curve Chronobiol Int 9 5 1992 380-392
28. J.E. Chase B.E. Gidal Melatonin: Therapeutic use in sleep disorders Ann Pharmacother 31 10 1997 1218-1226
29. C. Cajochen K. Krauchi A. Wirz-Justice Role of melatonin in the regulation of human circadian rhythms and sleep J Neuroendocrinol 15 4 2003 432-437
30. A.J. Lewy R.L. Sack Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: A brief review and critique of the literature J Biol Rhythms 12 6 1997 588-594
31. F. Waldhauser M. Waldhauser H.R. Lieberman et al. Bioavailability of oral melatonin in humans Neuroendocrinology 39 4 1984 307-313
32. S.M. Reppert Melatonin receptors: Molecular biology of a new family of G protein-coupled receptors J Biol Rhythms 12 6 1997 528-531
33. R.L. DeMuro A.N. Nafziger D.E. Blask et al. The absolute bioavailability of oral melatonin J Clin Pharmacol 40 7 2000 781-784
34. D. Le Bars P. Thivolle P.A. Vitte et al. PET and plasma pharmacokinetic studies after bolus intravenous administration of [ 11 C]melatonin in humans Int J Rad Appl Instrum B 18 3 1991 357-362
35. B. Claustrat D. Le Bars J. Brun et al. Plasma and brain pharmacokinetic studies in humans after intravenous administration of cold or 11 C labeled melatonin Adv Pineal Res 3 1989 305-310
36. O. Uchikawa K. Fukatsu R. Tokunoh et al. Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists J Med Chem 45 19 2002 4222-4239
37. C. von Gall J.H. Stehle D.R. Weaver Mammalian melatonin receptors: molecular biology and signal transduction Cell Tissue Res 309 1 2002 151-162
38. A.E. Hunt W.M. Al Ghoul Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock Am J Physiol Cell Physiol 280 1 2001 C110-C118
39. O. Nosjean M. Ferro F. Coge et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2 J Biol Chem 275 40 2000 31311-31317
40. O. Nosjean J.P. Nicolas F. Klupsch et al. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 Biochem Pharmacol 61 11 2001 1369-1379
41. V. Audinot F. Mailliet C. Lahaye-Brasseur et al. New selective ligands of human cloned melatonin MT1 and MT2 receptors Naunyn Schmiedebergs Arch Pharmacol 367 6 2003 553-561
42. S. Yous J. Andrieux H.E. Howell et al. Novel naphthalenic ligands with high affinity for the melatonin receptor J Med Chem 35 8 1992 1484-1486
43. D.N. Krause M.L. Dubocovich Regulatory sites in the melatonin system of mammals Trends Neurosci 13 11 1990 464-470
44. M. Ebadi P. Govitrapong Neural pathways and neurotransmitters affecting melatonin synthesis J Neural Transm Suppl 21 1986 125-155
45. J. Axelrod The pineal gland: A neurochemical transducer Science 184 144 1974 1341-1348
46. R.J. Reiter Pineal melatonin: Cell biology of its synthesis and of its physiological interactions Endocr Rev 12 2 1991 151-180
47. D.C. Klein R.Y. Moore Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: Control by the retinohypothalamic tract and the suprachiasmatic nucleus Brain Res 174 2 1979 245-262
48. A.J. Lewy L.J. Siever T.W. Uhde S.P. Markey Clonidine reduces plasma melatonin levels J Pharm Pharmacol 38 7 1986 555-556
49. P.J. Cowen J.S. Bevan B. Gosden S.A. Elliott Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration Br J Clin Pharmacol 19 2 1985 258-260
50. I.M. McIntyre G.D. Burrows T.R. Norman Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans Biol Psychiatry 24 1 1988 108-112
51. A.J. Lewy T.A. Wehr F.K. Goodwin et al. Light suppresses melatonin secretion in humans Science 210 4475 1980 1267-1269
52. J.A. Gastel P.H. Roseboom P.A. Rinaldi et al. Melatonin production: proteasomal proteolysis in serotonin N-acetyltransferase regulation Science 279 5355 1998 1358-1360
53. D.M. Berson F.A. Dunn M. Takao Phototransduction by retinal ganglion cells that set the circadian clock Science 295 5557 2002 1070-1073
54. S. Hattar H.W. Liao M. Takao et al. Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity Science 295 5557 2002 1065-1070
55. H. Okamura S. Miyake Y. Sumi et al. Photic induction of mPer1 and mPer2 in cry-deficient mice lacking a biological clock Science 286 5449 1999 2531-2534
56. P.L. Lowrey J.S. Takahashi Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation Annu Rev Genet 34 2000 533-562
57. X. Jin C. von Gall R.L. Pieschl et al. Targeted disruption of the mouse Mel(1b) melatonin receptor Mol Cell Biol 23 3 2003 1054-1060
58. M.L. Dubocovich K. Yun W.M. Al Ghoul et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms Fed Am Soc Eur Biol J 12 12 1998 1211-1220
59. D.R. Weaver C. Liu S.M. Reppert Nature's knockout: The Mel1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters Mol Endocrinol 10 11 1996 1478-1487
60. S. Rivara M. Mor C. Silva et al. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: Requirements for subtype selectivity and intrinsic activity modulation J Med Chem 46 8 2003 1429-1439
61. D. Sugden L.K. Yeh M.T. Teh Design of subtype selective melatonin receptor agonists and antagonists Reprod Nutr Dev 39 3 1999 335-344
62. V. Wallez S. Durieux-Poissonnier P. Chavatte et al. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands J Med Chem 45 13 2002 2788-2800
63. S. Yous S. Durieux-Poissonnier E. Lipka-Belloli et al. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands Bioorg Med Chem 11 5 2003 753-759
64. M.I. Masana S. Benloucif M.L. Dubocovich Circadian rhythm of mt1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse J Pineal Res 28 3 2000 185-192
65. V.J. Poirel M. Masson-Pevet P. Pevet F. Gauer MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei Brain Res 946 1 2002 64-71
66. J.M. Neu L.P. Niles A marked diurnal rhythm of melatonin ML1A receptor mRNA expression in the suprachiasmatic nucleus Brain Res Mol Brain Res 49 1-2 1997 303-306
67. M.L. Dubocovich S. Benloucif M.I. Masana Melatonin receptors in the mammalian suprachiasmatic nucleus Behav Brain Res 73 1-2 1996 141-147
68. C. Schuster F. Gauer A. Malan et al. The circadian clock, light/dark cycle and melatonin are differentially involved in the expression of daily and photoperiodic variations in mt(1) melatonin receptors in the Siberian and Syrian hamsters Neuroendocrinology 74 1 2001 55-68
69. A.B. Dollins I.V. Zhdanova R.J. Wurtman et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance Proc Natl Acad Sci USA 91 5 1994 1824-1828
70. O. Tzischinsky P. Lavie Melatonin possesses time-dependent hypnotic effects Sleep 17 7 1994 638-645
71. E.J. Van Someren More than a marker: Interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities Chronobiol Int 17 3 2000 313-354
72. O. Tzischinsky A. Shlitner P. Lavie The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin J Biol Rhythms 8 3 1993 199-209
73. H.J. Lynch R.J. Wurtman M.A. Moskowitz et al. Daily rhythm in human urinary melatonin Science 187 4172 1975 169-171
74. D.P. Cardinali L.I. Brusco S.P. Lloret A.M. Furio Melatonin in sleep disorders and jet-lag Neuroendocrinol Lett 23 Suppl 1 2002 9-13
75. W.B. Mendelson Efficacy of melatonin as a hypnotic agent J Biol Rhythms 12 6 1997 651-656
76. I.V. Zhdanova R.J. Wurtman Efficacy of melatonin as a sleep-promoting agent J Biol Rhythms 12 6 1997 644-650
77. N. Zisapel The use of melatonin for the treatment of insomnia Biol Signals Recept 8 1-2 1999 84-89
78. A. Brzezinski Melatonin in humans N Engl J Med 336 3 1997 186-195
79. R.L. Sack A.J. Lewy R.J. Hughes Use of melatonin for sleep and circadian rhythm disorders Ann Med 30 1 1998 115-121
80. R. Sahelian Use of melatonin for insomnia Am Fam Physician 57 8 1998 1783-1787
81. I.V. Zhdanova R.J. Wurtman C. Morabito et al. Effects of low oral doses of melatonin, given 2-4 h before habitual bedtime, on sleep in normal young humans Sleep 19 5 1996 423-431
82. S.P. James W.B. Mendelson D.A. et al. Sack The effect of melatonin on normal sleep Neuropsychopharmacology 1 1 1987 41-44
83. D.C. Skinner B. Malpaux High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus Endocrinology 140 10 1999 4399-4405
84. N.L. Rogers D.F. Dinges D.J. Kennaway D. Dawson Potential action of melatonin in insomnia Sleep 26 8 2003 1058-1059
85. D. Dawson N.L. Rogers C.J. van den Heuvel et al. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs J Biol Rhythms 13 6 1998 532-538
86. D. Garfinkel M. Laudon D. Nof N. Zisapel Improvement of sleep quality in elderly people by controlled-release melatonin Lancet 346 8974 1995 541-544
87. I. Haimov P. Lavie M. Laudon et al. Melatonin replacement therapy of elderly insomniacs Sleep 18 7 1995 598-603
88. R.J. Hughes R.L. Sack A.J. Lewy The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement Sleep 21 1 1998 52-68
89. G. Jean-Louis H. von Gizycki F. Zizi Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment J Pineal Res 25 3 1998 177-183
90. F. Waldhauser G. Weiszenbacher E. Tatzer et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging J Clin Endocrinol Metab 66 3 1988 648-652
91. M. Sharma J. Palacios-Bois G. Schwartz et al. Circadian rhythms of melatonin and cortisol in aging Biol Psychiatry 25 3 1989 305-319
92. Y. Ohashi N. Okamoto K. Uchida et al. Differential pattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects Biol Signals 6 4-6 1997 301-306
93. D.R. Thomas A. Miles Melatonin secretion and age Biol Psychiatry 25 3 1989 365-367
94. F. Waldhauser J. Kovacs E. Reiter Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders Exp Gerontol 33 7-8 1998 759-772
95. J.M. Zeitzer J.E. Daniels J.F. Duffy et al. Do plasma melatonin concentrations decline with age? Am J Med 107 5 1999 432-436
96. R.Y. Liu J.N. Zhou J. van Heerikhuize Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging. Alzheimer's disease, and apolipoprotein E-epsilon 4/4 genotype J Clin Endocrinol Metab 84 1 1999 323-327
97. K. Mishima T. Tozawa K. Satoh et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking Biol Psychiatry 45 4 1999 417-421
98. Y. Ohashi N. Okamoto K. Uchida et al. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type Biol Psychiatry 45 12 1999 1646-1652
99. L. Volicer D.G. Harper B.C. Manning et al. Sundowning and circadian rhythms in Alzheimer's disease Am J Psychiatry 158 5 2001 704-711
100. S.M. McCurry C.F. Reynolds S. Ancoli-Israel et al. Treatment of sleep disturbance in Alzheimer's disease Sleep Med Rev 4 6 2000 603-628
101. L.I. Brusco M. Marquez D.P. Cardinali Monozygotic twins with Alzheimer's disease treated with melatonin: Case report J Pineal Res 25 4 1998 260-263
102. L.I. Brusco I. Fainstein M. Marquez D.P. Cardinali Effect of melatonin in selected populations of sleep-disturbed patients Biol Signals Recept 8 1-2 1999 126-131
103. J. Cohen-Mansfield D. Garfinkel S. Lipson Melatonin for treatment of sundowning in elderly persons with demen Arch Gerontol Geriatr 31 1 2000 65-76
104. K. Mishima M. Okawa S. Hozumi Y. Hishikawa Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons Chronobiol Int 17 3 2000 419-432
105. D. Garfinkel N. Zisapel J. Wainstein M. Laudon Facilitation of benzodiazepine discontinuation by melatonin: A new clinical approach Arch Intern Med 159 20 1999 2456-2460
106. J. Arendt C. Bojkowski S. Folkard et al. Some effects of melatonin and the control of its secretion in humans Ciba Found Symp 117 1985 266-283
107. J. Arendt D.J. Skene B. Middleton Efficacy of melatonin treatment in jet lag, shift work, and blindness J Biol Rhythms 12 6 1997 604-617
108. S.M. Armstrong V.M. Cassone M.J. Chesworth et al. Synchronization of mammalian circadian rhythms by melatonin J Neural Transm Suppl 21 1986 375-394
109. S. Deacon J. Arendt Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans Brain Res 688 1-2 1995 77-85
110. C. Mallo R. Zaidan A. Faure et al. Effects of a four-day nocturnal melatonin treatment on the 24 h plasma melatonin, cortisol and prolactin profiles in humans Acta Endocrinol (Copenh) 119 4 1988 474-480
111. A.J. Lewy V.K. Bauer S. Ahmed The human phase response curve (PRC) to melatonin is about 12 h out of phase with the PRC to light Chronobiol Int 15 1 1998 71-83
112. A.J. Lewy D.A. Newsome Different types of melatonin circadian secretory rhythms in some blind subjects J Clin Endocrinol Metab 56 6 1983 1103-1107
113. D.J. Skene S.W. Lockley J. Arendt Melatonin in circadian sleep disorders in the blind Biol Signals Recept 8 1-2 1999 90-95
114. D. Leger C. Guilleminault R. Defrance et al. Prevalence of sleep/wake disorders in persons with blindness Clin Sci (Lond) 97 2 1999 193-199
115. D. Leger E. Prevot P. Philip et al. Sleep disorders in children with blindness Ann Neurol 46 4 1999 648-651
116. R.L. Sack A.J. Lewy M.L. Blood Melatonin administration to blind people: phase advances and entrainment J Biol Rhythms 6 3 1991 249-261
117. S. Folkard J. Arendt M. Aldhous H. Kennett Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms Neurosci Lett 113 2 1990 193-198
118. L. Palm G. Blennow L. Wetterberg Correction of non-24-h sleep/wake cycle by melatonin in a blind retarded boy Ann Neurol 29 3 1991 336-339
119. D.J. Skene S.W. Lockley J. Arendt Use of melatonin in the treatment of phase shift and sleep disorders Adv Exp Med Biol 467 1999 79-84
120. H.J. Burgess K.M. Sharkey C.I. Eastman Bright light, dark and melatonin can promote circadian adaptation in night shift workers Sleep Med Rev 6 5 2002 407-420
121. R.L. Sack A.J. Lewy Melatonin as a chronobiotic: Treatment of circadian desynchrony in night workers and the blind J Biol Rhythms 12 6 1997 595-603
122. K.M. Sharkey C.I. Eastman Melatonin phase shifts human circadian rhythms in a placebo-controlled simulated night-work study Am J Physiol Regul Integr Comp Physiol 282 2 2002 R454-R463
123. K.M. Sharkey L.F. Fogg C.I. Eastman Effects of melatonin administration on daytime sleep after simulated night shift work J Sleep Res 10 3 2001 181-192
124. A. Herxheimer K.J. Petrie Melatonin for preventing and treating jet lag Cochrane Database Syst Rev 1 2001 CD001520
125. D. Dawson N. Encel K. Lushington Improving adaptation to simulated night shift: Timed exposure to bright light versus daytime melatonin administration Sleep 18 1 1995 11-21
126. N. Zisapel Circadian rhythm sleep disorders: Pathophysiology and potential approaches to management CNS Drugs 15 4 2001 311-328
127. M.J. Millan A. Gobert F. Lejeune et al. The novel melatonin agonist agomelatine (S8) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways J Pharmacol Exp Ther 306 3 2003 954-964
128. M. Papp P. Gruca P.A. Boyer E. Mocaer Effect of agomelatine in the chronic mild stress model of depression in the rat Neuropsychopharmacology 28 4 2003 694-703
129. C. Kopp E. Vogel M. Rettori et al. Anxiolytic-like properties of melatonin receptor agonists in mice: Involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness Neuropharmacology 39 10 2000 1865-1871
130. S.W. Ying B. Rusak P. Delagrange Melatonin analogues as agonists and antagonists in the circadian system and other brain areas Eur J Pharmacol 296 1 1996 33-42
131. L. Weibel F.W. Turek E. Mocaer O. Van Reeth A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle Brain Res 880 1-2 2000 207-211
132. O. Van Reeth E. Olivares F.W. Turek et al. Resynchronisation of a diurnal rodent circadian clock accelerated by a melatonin agonist Neuroreport 9 8 1998 1901-1905
133. J.R. Redman B. Guardiola-Lemaitre M. Brown et al. Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms Psychopharmacology (Berl) 118 4 1995 385-390
134. J.R. Redman A.J. Francis Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal J Biol Rhythms 13 1 1998 39-51
135. N. Yukuhiro H. Nishikawa H. Kimura et al. Sleep in freely moving monkeys: Comparison of TAK-375, melatonin, and Zolpidem Sleep 26 2003 A80
136. K. Hirai K. Kato K. Nishiyama et al. TAK-375 and its metabolites are selective agonists at ML-1 receptors Sleep 26 2003 A79
137. C.M. Stubbs A. Karim A safety, tolerance, and pharmacokinetic study of five single doses of TAK-375 in healthy adults Sleep 26 2003 A76-A77
138. M. Miyamoto K. Kato K. Hirai et al. TAK-375 and its active metabolite: lack of binding to non-ML receptor binding sites Sleep 26 2003 A79
139. Kato K. Hirai K. Nishiyama K. Uchikawa O. Fukatsu K. Ohkawa S. Kawonata Y. Hinuma S. Miyamoto M. Neuropharmacology of ramelteon (TAK 375) a selective Mt/MT receptor against Neuropharmacology: Submitted for published
140. T. Roth J.K. Walsh Phase II study of the selective ML-1 receptor agonist TAK-375 in a first night effect model of transient insomnia Sleep 26 2003 A294
141. M. Erman D. Seiden G. Zammit Phase II study of the selective ML-1 receptor agonist TAK-375 in subjects with primary chronic insomnia Sleep 26 2003 A298
142. M.E. Flaugh R.F. Bruns L.A. Shipley J.A. Clemens Beta-substituted melatonin analogs In: S.M. Webb M. Puig-Domingo M. Moller P. Pevet (Eds.) Pineal update: From molecular mechanisms to clinical implications 1997 PJD Publications, Ltd Westburg, NY 321-330
143. T. Nickelsen A. Samel M. Vejvoda et al. Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9 h time shift: results of a placebo-controlled trial Chronobiol Int 19 5 2002 915-936
144. L.R. Levine B.P. Smith LY 156735, a melatonin analog, reduces sleep-onset latency in patients with moderate sleep-onset insomnia Abstracts of 37th Annual Meeting of the American College of Neuropsychopharmacology 1998
145. M.J. Goldberg R.F. Bergstrom B.P. Smith LY 156735, a melatonin agonist: Phase 1 pharmacokinetic and pharmacodynamic studies Abstracts of Papers, 37th Annual Meeting of the American College of Neuropsychopharmacology 1998